A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Condition:   Ulcerative Colitis Interventions:   Drug: LT-02;   Drug: LT-02 Placebo Sponsors:   Prometheus Laboratories;   Nestlé Health Science Spain;   INC Research Recruiting - verified August 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2016 Category: Research Source Type: clinical trials

A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
< b > Condition < /b > :   Ulcerative Colitis < br/ > < b > Interventions < /b > :   Drug: LT-02;   Drug: LT-02 Placebo < br/ > < b > Sponsors < /b > :   Prometheus Laboratories;   Nestlè Health Science;   INC Research < br/ > < b > Recruiting < /b > - verified July 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 26, 2016 Category: Research Source Type: clinical trials